Quantitative proteomic profiling identifies global protein network dynamics in murine embryonic heart development.

Area of Science:

• Developmental Biology
• Proteomics
• Cardiovascular Research

Background:

• Understanding embryonic heart development is key to addressing congenital heart disease.
• Temporal proteomic changes are largely uncharacterized during critical developmental stages.

Purpose of the Study:

• To quantitatively profile the murine embryonic heart proteome over time.
• To identify protein dynamics and molecular pathways involved in heart development.
• To uncover novel regulatory mechanisms contributing to congenital heart disease.

Main Methods:

• Quantitative proteomics was employed to analyze protein expression.
• Over 7,300 proteins were quantified at critical murine embryonic heart development stages.
• Protein interaction networks and temporal profiles were analyzed.

Main Results:

• Global temporal proteomic profiles revealed signature cardiac protein interaction networks.
• Protein dynamics were linked to specific molecular pathways.
• The mevalonate pathway was identified and functionally validated in regulating embryonic cardiomyocyte cell cycle.

Conclusions:

• Proteomic datasets provide a valuable resource for studying embryonic heart development.
• Insights into protein dynamics offer new avenues for understanding congenital heart disease etiology.
• The mevalonate pathway represents a potential therapeutic target for heart development disorders.